文献速递心脑血管急症重症综合管理与镇静镇痛

无阻塞性冠状动脉疾病患者的炎症风险与心血管事件:ORFAN多中心纵向队列研究

Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study.
PubMed 文献 · Lancet · 2024-05-29
一句话结论在无阻塞性冠脉疾病患者中,基于CCTA的FAI Score可独立预测心源性死亡和MACE,AI-Risk模型整合炎症信息或可替代传统风险计算器。

ORFAN多中心纵向队列纳入英国8家医院40 091例临床指征行CCTA的连续患者,中位随访2.7年,评估FAI Score在有无阻塞性CAD时的预后价值,并外部验证AI-Risk算法。无阻塞性CAD患者占81.1%(32 533/40 091),却贡献66.3%(2857/4307)的MACE和63.7%(1118/1754)的心源性死亡。三支冠脉FAI Score均位于最高四分位者,心源性死亡HR 29.8(95%CI 13.9-63.9,p<0.001)、MACE HR 12.6(95%CI 8.5-18.6,p<0.001)。AI-Risk分类与心源性死亡(极高危vs低/中危HR 6.75,95%CI 5.17-8.82,p<0.001)和MACE(HR 4.68,95%CI 3.93-5.57,p<0.001)正相关,模型校准良好。

要点

  • 无阻塞性CAD患者占CCTA人群81.1%(32 533/40 091),却发生66.3%(2857/4307)的MACE和63.7%(1118/1754)的心源性死亡。
  • 三支冠脉FAI Score均位于最高四分位(vs 均最低四分位)者,心源性死亡HR 29.8(95%CI 13.9-63.9,p<0.001),MACE HR 12.6(95%CI 8.5-18.6,p<0.001)。
  • 任一冠脉FAI Score可独立于心血管危险因素及CAD存在与否/范围预测心源性死亡和MACE。
  • AI-Risk分类极高危vs低/中危:心源性死亡HR 6.75(95%CI 5.17-8.82,p<0.001),MACE HR 4.68(95%CI 3.93-5.57,p<0.001)。
  • AI-Risk模型对真实事件校准良好,作者认为可替代传统基于危险因素的风险计算器。

适用人群与场景

  • 英国8家医院因临床指征行CCTA的连续患者40 091例(Cohort A),中位随访2.7年(IQR 1.4-5.3)。
  • FAI Score预后评估在随访最长的两家医院3393例连续患者中进行,随访7.7年(IQR 6.4-9.1)。
  • 包括有或无阻塞性冠状动脉疾病(CAD)的患者。

研究设计与关键结果

  • 多中心纵向队列,40 091例,8家英国医院,中位随访2.7年(IQR 1.4-5.3)。
  • 无阻塞性CAD者32 533例(81.1%),贡献2857/4307(66.3%)MACE和1118/1754(63.7%)心源性死亡。
  • 三支冠脉FAI Score均处最高vs最低四分位:心源性死亡HR 29.8(95%CI 13.9-63.9,p<0.001),MACE HR 12.6(95%CI 8.5-18.6,p<0.001)。
  • AI-Risk分类极高危vs低/中危:心源性死亡HR 6.75(95%CI 5.17-8.82,p<0.001),MACE HR 4.68(95%CI 3.93-5.57,p<0.001)。
  • AI-Risk模型对真实事件校准良好。

证据类型、等级与局限

  • 证据类型:多中心纵向队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为FAI Score可捕捉当前临床风险分层和CCTA判读之外的炎症风险,尤其在无阻塞性CAD患者中。
  • 作者认为AI-Risk模型整合炎症信息,可作为传统基于危险因素的风险计算器的替代。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Coronary computed tomography angiography (CCTA) is the first line investigation for chest pain, and it is used to guide revascularisation. However, the widespread adoption of CCTA has revealed a large group of individuals without obstructive coronary artery disease (CAD), with unclear prognosis and management. Measurement of coronary inflammation from CCTA using the perivascular fat attenuation index (FAI) Score could enable cardiovascular risk prediction and guide the management of individuals without obstructive CAD. The Oxford Risk Factors And Non-invasive imaging (ORFAN) study aimed to evaluate the risk profile and event rates among patients undergoing CCTA as part of routine clinical care in the UK National Health Service (NHS); to test the hypothesis that coronary arterial inflammation drives cardiac mortality or major adverse cardiac events (MACE) in patients with or without CAD; and to externally validate the performance of the previously trained artificial intelligence (AI)-Risk prognostic algorithm and the related AI-Risk classification system in a UK population.

METHODS: This multicentre, longitudinal cohort study included 40 091 consecutive patients undergoing clinically indicated CCTA in eight UK hospitals, who were followed up for MACE (ie, myocardial infarction, new onset heart failure, or cardiac death) for a median of 2·7 years (IQR 1·4-5·3). The prognostic value of FAI Score in the presence and absence of obstructive CAD was evaluated in 3393 consecutive patients from the two hospitals with the longest follow-up (7·7 years [6·4-9·1]). An AI-enhanced cardiac risk prediction algorithm, which integrates FAI Score, coronary plaque metrics, and clinical risk factors, was then evaluated in this population.

FINDINGS: In the 2·7 year median follow-up period, patients without obstructive CAD (32 533 [81·1%] of 40 091) accounted for 2857 (66·3%) of the 4307 total MACE and 1118 (63·7%) of the 1754 total cardiac deaths in the whole of Cohort A. Increased FAI Score in all the three coronary arteries had an additive impact on the risk for cardiac mortality (hazard ratio [HR] 29·8 [95% CI 13·9-63·9], p<0·001) or MACE (12·6 [8·5-18·6], p<0·001) comparing three vessels with an FAI Score in the top versus bottom quartile for each artery. FAI Score in any coronary artery predicted cardiac mortality and MACE independently from cardiovascular risk factors and the presence or extent of CAD. The AI-Risk classification was positively associated with cardiac mortality (6·75 [5·17-8·82], p<0·001, for very high risk vs low or medium risk) and MACE (4·68 [3·93-5·57], p<0·001 for very high risk vs low or medium risk). Finally, the AI-Risk model was well calibrated against true events.

INTERPRETATION: The FAI Score captures inflammatory risk beyond the current clinical risk stratification and CCTA interpretation, particularly among patients without obstructive CAD. The AI-Risk integrates this information in a prognostic algorithm, which could be used as an alternative to traditional risk factor-based risk calculators.

FUNDING: British Heart Foundation, NHS-AI award, Innovate UK, National Institute for Health and Care Research, and the Oxford Biomedical Research Centre.

来源:Lancet,查看原文。版权归原作者所有。

参考来源

  1. Chan K, Wahome E, Tsiachristas A, et al. Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study. Lancet. 2024. PMID: 38823406. doi:10.1016/S0140-6736(24)00596-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。